Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

9

Number of overlapping holdings

14.1%

% of XLV's 65 holdings also in XPH

22.5%

% of XPH's 40 holdings also in XLV

Overlap by Weight
Sector Drift (XLV minus XPH)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in XLV
Weight
in XPH
Overlap
ELI LILLY & CO 5.5% 4.5% 4.5%
PFIZER INC 4.7% 4.3% 4.3%
JOHNSON & JOHNSON 8.3% 4.2% 4.2%
MERCK & CO. INC. 5.5% 4.1% 4.1%
BRISTOL-MYERS SQUIBB CO 3.0% 4.3% 3.0%

Position Highlights (Non-Overlapping Exposures)
XLV Overweight Relative to XPH
UNITEDHEALTH GROUP INC 9.3%
ABBVIE INC 5.8%
THERMO FISHER SCIENTIFIC INC 4.6%
JOHNSON & JOHNSON 4.1%
ABBOTT LABORATORIES 3.6%
DANAHER CORP 3.4%
AMGEN INC 2.6%
ANTHEM INC 2.3%
MEDTRONIC PLC 2.2%
GILEAD SCIENCES INC 2.1%
XLV Underweight Relative to XPH
ROYALTY PHARMA PLC CLASS A -4.5%
AXSOME THERAPEUTICS, INC. -4.5%
JAZZ PHARMACEUTICALS PLC -4.4%
ORGANON & CO. -3.9%
PERRIGO CO -3.9%
ELANCO ANIMAL HEALTH, INC. -3.9%
CATALENT INC -3.7%
VIATRIS, INC. -3.7%
REVANCE THERAPEUTICS INC -3.6%
CASSAVA SCIENCES, INC. -3.5%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY